Colonization with vancomycinresistant enterococci in. Prompt identification of colonized patients combined with effective multifaceted infection control practices can reduce the transmission of vre and aid in the prevention of hospitalacquired infections hais. To assess the rate of fecal vancomycinresistant enterococci vre colonization in australia, we examined specimens from 1,085 healthy volunteers. We describe the transmission of nosocomial pathogens by using a microepidemiological framework based on the. Their increased prevalence and their ability to transfer vancomycin resistance to other bacteria including methicillin resistant staphylococcus aureus have made them a subject of close scrutiny and intense investigation. Trends and significance of vre colonization in the icu. This study aimed to determine the incidence, risk factors, and clinical outcomes of intestinal co. Vancomycinresistant enterococci have emerged as important nosocomial pathogens and represent a serious threat to patients with impaired host defenses. Patients with acute leukemia were at higher risk for vre colonization risk ratio rr 1. Vancomycin resistant enterococci vre are both of medical and public health importance associated with serious multidrug resistant infections and persistent colonization.
Fecal microbiota transplantation to eradicate vancomycinresistant. May 07, 2020 to assess the rate of fecal vancomycin resistant enterococci vre colonization in australia, we examined specimens from 1,085 healthy volunteers. To determine the prevalence of gastrointestinal colonization with vancomycin resistant enterococci in hospitalized and outpatients. Vre colonisation increases the risk of developing infection up to 510 folds. Analysis from the national nosocomial infections surveillance system at the centers for disease control and prevention has demonstrated a 20fold increase in nosocomial infections due to vancomycin resistant enterococci vre. Of the 16 patients who cleared vre colonization, received antibiotic therapy during the study period. Vancomycin resistant enterococci have emerged as important nosocomial pathogens and represent a serious threat to patients with impaired host defenses. Vancomycinresistant enterococci vre have emerged as one of the most important nosocomial pathogens and may result in severe bloodstream, intraabdominal, and urinary tract infections 1,2,3. The median number of days until acquisition of vancomycin resistant enterococci vre in relation to the colonization pressure prevalence and enteral feeding. Symptoms and signs depend upon the site of vre infection. Enterococci are opportunistic environmental inhabitants with a remarkable adaptive capacity to evolve and transmit antimicrobialresistant determinants. Vancomycinresistant enterococcus vre has been identified with increased frequency in dialysis populations, but the risk factors for vre colonization are not well defined in hemodialysis patients. This development limits the therapeutic options for treating serious infections. Epidemiology of colonisation of patients and environment.
Vre infection can easily be spread from person to person. Vancomycinresistant enterococci vre recently have emerged as a nosocomial pathogen especially in intensivecare units icus worldwide. We describe a patient with leukemia who developed prolonged colonization with vancomycinresistant enterococcus faecium and ultimately died of sepsis due to this multidrugresistant organism. We analyzed surveillance cultures for vancomycin resistant enterococci vre and methicillin resistant staphylococcus aureus mrsa collected during a multicenter trial to determine if three negative cultures collected at weekly intervals would predict clearance of vre or mrsa from colonized patients. The intestinal microbiota provides resistance against vre colonization. However, vre is resistant to vancomycin and makes it difficult to treat. However, the actual incidence of and risk factors for vre remain unclear.
Learn about vre spread, colonization, and precautions. Epidemiology of colonisation of patients and environment with. Vancomycin resistant enterococci colonization in a neonatal intensive care unit. Intestinal colonization of a human subject by vancomycin. Vancomycin resistant enterococci vre are becoming a major concern in medical practice. Vancomycinresistant enterococcus vre can densely colonize intestines and cause bloodstream infections.
Vancomycinresistant enterococci vre were first reported in 1986 and have since evolved into a major cause of healthcareassociated infections, and their prevalence in the united states is reportedly increasing. Evaluating hospital infection control measures for. Summary after they were first identified in the mid1980s, vancomycinresistant enterococci vre spread rapidly and became a major problem in many institutions both in europe and the united states. Vancomycinresistant enterococci colonization in a neonatal. C storage of specimens does not affect the recovery of enterococci in general, or vre in particular. Fecal colonization with vancomycinresistant enterococci in australia. Risk factors for longterm vancomycinresistant enterococci. Colonization and infection with vancomycinresistant enterococci vre are emerging worldwide. Enterococci are common, increasingly antibioticresistant gut microbes that grow as diplococci in liquid media. Five patients had vre strains available for pfge analysis. Infections attributable to vancomycinresistant enterococcus vre strains have become increasingly prevalent over the past decade. Gut colonization with vancomycinresistant enterococcus and risk for. Vancomycin resistant enterococci vre have emerged as nosocomial pathogens during the past 5 years, but little is known about the epidemiology of vre. Vancomycin resistant enterococci vre are widespread nosocomial pathogens, whose main site of colonization is the intestinal tract, leading to asymptomatic digestive carriage and hence to the formation of a reservoir of vre.
We performed parallel searches in ovid medline for studies that reported the time to documented clearance. Patients with hematological malignancies or undergoing hematopoietic stem cell transplantation are vulnerable to colonization and infection with multidrugresistant organisms, including vancomycinresistant enterococcus faecium vrefm. Little is known about risk factors for subsequent infections among vancomycin resistant enterococcus faecium vrefm colonizers, especially characterized by concordant pulsotypes cp of paired colonization and infectionrelated isolates. The increase in antibiotic resistance and transfer of antibiotic resistance gene to staphylococcus aureus s. Nasal and perirectal colonization of vancomycin sensitive. Risk factors for vancomycinresistant enteroccocci colonization in. In 1999, a greek study conducted to determine the increased spread of vre colonization reported a prevalence of vre colonization of 1. The emergence of vancomycinresistant staphylococcus aureus vrsa has become a global concern for public health. If these germs develop resistance to vancomycin, an antibiotic that is used to treat some drugresistant infections, they become vancomycinresistant. Colonization with vancomycinresistant enterococci and risk.
Seventytwo percent of vrecolonized patients and 94% of mrsacolonized patients were culture. In the us, linezolid is commonly used to treat vre. Vancomycinresistant enterococci vre are both of medical and public health importance associated with serious multidrugresistant infections and persistent colonization. First, to verify that 70c storage did not affect the overall recovery of enterococci, a randomly selected subset of 112 of the 1,085 specimens were cultured on enterococcosal agar bbl without. Pretransplant gut colonization with intrinsically vancomycin. Enterococci bacteria are constantly finding new ways to avoid the effects of the antibiotics used to treat the infections they cause. Vancomycinresistant enterococci vre are widespread nosocomial pathogens, whose main site of colonization is the intestinal tract, leading to asymptomatic digestive carriage and hence to the formation of a reservoir of vre.
Once colonized, patients are at greater risk of developing subsequent infections or of transmitting vre to other patients. Understanding these pathogens and assessing methods for their control continues to be an area of considerable importance see. The emergence of antimicrobialresistant pathogens such as methicillinresistant staphylococcus aureus mrsa and vancomycinresistant enterococci vre during the past two decades is a major clinical and epidemiological problem throughout the world. Vancomycinresistant enterococcus faecium colonization in. The first isolates of highlevel vancomycin resistant enterococci vre were reported from the united kingdom in the late 1980s.
Natural history of colonization with vancomycinresistant. Surveillance of intestinal colonization and of infection. Predictors for vancomycin resistant enterococcus faecium. Transmission via the hands of healthcare workers is an important determinant of spread and persistence in a vreendemic icu.
The present study was conducted in order to clarify the incidence. Patients undergoing dialysis represent a vulnerable population due to their comorbid conditions, frequent use of antibacterial agents, and frequent contact with health care settings. Vancomycinresistant enterococci colonization among dialysis. Recurrence of vancomycin resistant enterococcus stool colonization during antibiotic therapy volume 23 issue 8 curtis j. We assessed the prevalence, risk factors, and clinical outcomes of patients cocolonized with vancomycinresistant enterococci vre and methicillinresistant staphylococcus aureus mrsa upon admission to the medical and surgical intensive care units icus of a tertiarycare facility between january 1, 2002, and december 31, 2003. We performed a retrospective cohort study of adults admitted to an icu from 2012 to 2017 who were screened for vre colonization and subsequently underwent stool testing with a gastrointestinal. Fecal colonization with vancomycinresistant enterococci. Oct 10, 2019 the emergence of vancomycin resistant staphylococcus aureus vrsa has become a global concern for public health.
The evolution of antimicrobial resistance has become a global problem 2, 5, 20. The aim of the study was to evaluate local epidemiology of nasal and rectal. Whether vre colonization leads to infection depends on the health status of the patient. Gut colonization with vancomycinresistant enterococcus. Mar 15, 2002 the transmission dynamics of vancomycin resistant enterococci vre and factors contributing to their dissemination are complex. Wed like to understand how you use our websites in order to improve them. This study aimed to determine the incidence, risk factors, and clinical outcomes. The incidence of infection and intestinal colonization with vancomycin resistant enterococci vre is increasing in many countries in the last decade. Colonization resistance against vre requires commensal bacterial cooperation.
This casecontrol study was conducted at a teaching hospital between 2011 and 2014. Natural history of colonization with vancomycinresistant enterococci, methicillinresistant staphylococcus aureus, and resistant gramnegative bacilli among longtermcare facility residents volume 24 issue 4 glenn a. The proximity of vancomycin resistant enterococcus vre and methicillin resistant s. Determining the clinical significance of cocolonization. We and others have shown that vre colonization is associated with 3. However, at that time glycopeptides were not used in human medicine. Enterococci are opportunistic environmental inhabitants with a remarkable adaptive capacity to evolve and transmit antimicrobial resistant determinants. Colonization with vancomycinresistant enterococci and. Colonization with vancomycinresistant enterococci and risk for. Resistance mechanisms, epidemiology, and approaches to. Gut colonization with vancomycin resistant enterococcus vre is associated with poor outcomes.
Prolonged colonization with vancomycinresistant enterococcus faecium in longterm care patients. Vre is a strain of bacteria that can cause infection. Enterococci normally inhabit the intestinal tract of humans and are also a potential pathogen in causing nosocomial infections. Impact of persistent gastrointestinal colonization on the. Pdf we aimed to evaluate the risk factors for vre colonization in neonatal intensive care units. The prevalence of vancomycinresistant enterococci vre colonization or infection in the hospital setting has increased globally. Intestinal bile acids induce a morphotype switch in.
The aim of this crosssectional prevalence study was to determine the prevalence and risk factors of vre colonization in chronic hemodialysis patients in two hemodialysis centers in shiraz, iran. Evolution of vancomycinresistant enterococcus faecium. Prolonged colonization with vancomycinresistant enterococcus. Species were identified and isolates analyzed by pulsedfield gel. Kaplanmeier estimate of the duration of positive vre culture after discharge.
Vancomycin resistant enterococcus what you need to know. Enterococci are part of the normal flora of the gastrointestinal tract and one of the most important causes of nosocomial infections. Read about vancomycinresistant enterococci vre causes and treatment. Predicting clearance of colonization with vancomycin. Targeted patients received active surveillance culture for vrefm by anal. Concerning the difficult antimicrobial treatment of infections caused by vre, decreasing the incidence and prevalence of these infections is an important factor in vreinduced morbidity and mortality control. Administration of specific consortia of commensal bacteria can reestablish colonization.
Vancomycin resistant enterococci vre have become important nosocomial pathogens causing outbreaks worldwide. Vancomycin resistant enterococci vre were first reported in 1986 and have since evolved into a major cause of healthcareassociated infections, and their prevalence in the united states is reportedly increasing. Vancomycinresistant enterococci vre have emerged as nosocomial pathogens during the past 5 years, but little is known about the epidemiology of vre. The proximity of vancomycinresistant enterococcus vre and methicillinresistant s. Vancomycin resistant enterococcus vre is one of the leading causes of. Prevalence and risk factors for intestinal colonization with. Analysis from the national nosocomial infections surveillance system at the centers for disease control and prevention has demonstrated a 20fold increase in nosocomial infections due to vancomycinresistant enterococci vre. Cooperating commensals restore colonization resistance to. Patients from a universityaffiliated outpatient dialysis center had surveillance stool or rectal cultures for vre during april 1994 and january 1996. Colonization with vancomycinresistant enterococci in chronic. The prevalence of vancomycin resistant enterococci vre colonization or infection in the hospital setting has increased globally. Colonization with antibioticsusceptible strains protects against methicillin resistant staphylococcus aureus but not vancomycin resistant enterococci acquisition. Caballero and colleagues demonstrate in mice that blautia producta and clostridium bolteae restore resistance against vre. Vancomycinresistant enterococci vre have become important nosocomial pathogens causing outbreaks worldwide.
Determining the clinical significance of cocolonization of. Increasingly, the clinical microbiology laboratory is. Promptly implemented infection control strategies targeting these groups should help to combat the rising incidence of vre. Numerous variables and interactions need to be considered, including the duration of gastrointestinal vre colonization, the number of patients and health care workers hcws, the frequency of patient contacts, and. Vancomycinresistant enterococci vre cause severe infections among. Recurrence of vancomycinresistant enterococcus stool.
Vancomycin resistance among enterococci is increasing rapidly throughout the world. Methicillinresistant staphylococcus aureus and vancomycin. In europe, agricultural use of the glycopeptide growth promoter avoparcin has been implicated in the emergence of vana vre in the food chain 1, and fecal colonization rates of 2%28% have been reported in some communities 2,3. Probiotics and intestinal colonization by vancomycin. Fecal colonization with vancomycinresistant enterococci in. The increasing use of vancomycin for treatment of human infections with multiresistant grampositive bacteria has led to increasing concern over the size of the reservoir of vancomycinresistant enterococci, particularly enterococcus faecium, in poultry and pigs, which has arisen, it is thought, largely as a result of the. During a 41month period, over 7600 fecal samples and all samples from sterile sites from hospitalized cancer patients were screened for vre. Typically, asymptomatic vre gut colonization precedes infection with susceptible hosts comprising patients who are severely ill, exposed to multiple and prolonged courses of antimicrobial.
Duration of colonization and risk factors for prolonged carriage of. A retrospective analysis of a prospective surveillance for vre colonization and health careassociated infections was made. The first isolates of highlevel vancomycinresistant enterococci vre were reported from the united kingdom in the late 1980s. Read about vancomycin resistant enterococci vre causes and treatment. Gut colonization with vancomycinresistant enterococci vreenterococcus faecium and enterococcus faecalisis common. Vre most commonly causes an infection in the urinary tract, blood, or a wound. Prevalence of vancomycinresistant enterococci colonization. To determine the incidence of vancomycinresistant enterococcus vre colonization in our neonatal intensive care unit nicu over fiveyear period, rate of progression to vre infection and associated risk factors methods. Gastrointestinal colonization with vancomycinresistant.
Numerous variables and interactions need to be considered, including the duration of gastrointestinal vre colonization, the number of patients and health care workers hcws. Six different types of vancomycin resistance are shown by enterococcus. Cases were those who developed vrefm infection within 180 days after colonization of vrefm. In france, carbapenemresistant enterobacteriaceae cre and vancomycinresistant enterococci vre are considered as extensively drugresistant xdr bacteria. The significance is that vana vre is resistant to both vancomycin and teicoplanin, vanb vre is resistant to vancomycin but susceptible to teicoplanin, and vanc is only partly resistant to vancomycin. We investigated colonisation of patients and environmental contamination with vre in an endemic setting to assess the importance of different sources of colonisation. The emergence and spread of glycopeptide resistance in enterococci has become a substantial clinical and epidemiological concern, and vancomycinresistant enterococci vre are now an increasingly important problem in hospitals worldwide. If these germs develop resistance to vancomycin, an antibiotic that is used to treat some drug resistant. Over a 10y period, we collected and sequenced the genomes of 110 vrefm isolates from gastrointestinal and blood cultures of 24. Since vre colonization is generally thought to persist chronically in most patients, contact precautions are usually maintained over long periods.
Targeted patients received active surveillance culture for vrefm by. Mcdonald jr, engemann jj, kaye ks, sexton dj coinfection or co colonization with vancomycin resistant enterococci and methicillin resistant staphylococcus aureus in a network of community hospitals. Vancomycinresistant enterococci colonization among. Colonization with vre may persist for years, even if the results of intercurrent surveillance stool and. To assess the rate of fecal vancomycin resistant enterococci vre colonization in australia, we examined specimens from 1,085 healthy volunteers. Time to clearance of colonization has important implications for patient care and infection control policy.
Approximately 15% to 40% of patients are vre colonized before allogeneic hematopoietic cell transplantation allohct and an additional 10% become colonized within the first 100 days posthct. Since vre have intrinsic resistance to most of the commonly used antibiotics and the ability to acquire resistance to most of the current available antibiotics, either by mutation or by receipt. The role of colonization pressure in the spread of. We assessed the prevalence, risk factors, and clinical outcomes of patients cocolonized with vancomycin resistant enterococci vre and methicillin resistant staphylococcus aureus mrsa upon admission to the medical and surgical intensive care units icus of a tertiarycare facility between january 1, 2002, and december 31, 2003. Gut colonization with vancomycinresistant enterococcus and. Vancomycin resistant entrococci vre are increasing in prevalence at many institutions, and are often reported in dialysis patients.
We describe a patient with leukemia who developed prolonged colonization with vancomycin resistant enterococcus faecium and ultimately died of sepsis due to this multidrug resistant organism. Descriptive summary of vre infections by colonization status. This study evaluated the impact of vre colonization on subsequent acquisition of enteric pathogens. Feb 03, 2020 what is a vancomycin resistant enterococcus vre. Their management requires reinforcement of hospitals hygiene policies, and currently there is few consistent data concerning the spontaneous decolonization in xdr colonized patients. Many previous studies had analysed the risk factors for acquiring vre, based on crosssectional studies or prevalent cases. Vancomycinresistant enterococci can survive in the environment for prolonged periods 1 week, can contaminate almost any surface, and can be passed from one patient to another by health care workers.
Vancomycin resistant enterococcus vre has been identified with increased frequency in dialysis populations, but the risk factors for vre colonization are not well defined in hemodialysis patients. Clearance of vancomycinresistant enterococci vre carriage among eight. Riskfactors and predictors of mortality in patients colonised. Usually the antibiotic vancomycin is used to kill the bacteria. Natural history of colonization with methicillinresistant. Eight 62% of the patients who received antibiotics developed recurrent highdensity vre stool colonization range, 4.
Vancomycin resistant enterococci can survive in the environment for prolonged periods 1 week, can contaminate almost any surface, and can be passed from one patient to another by health care workers. Cephalosporin use is a risk factor for colonization and infection by vre, and restriction of cephalosporin usage has been associated with decreased vre infection and transmission in hospitals. Antibiotic resistance occurs when the germs no longer respond to the antibiotics designed to kill them. Colonization with antibioticsusceptible strains protects. Incidence of and risk factors for infection or colonization.
730 824 611 1074 129 1303 665 143 1535 1641 1288 1005 679 1015 685 1259 651 126 581 996 254 400 2 1414 1320 361 113 1403 1618 546 605 1196 666 540 345 1309 680 682